Correlation Between Apple and MAINZ BIOMED
Can any of the company-specific risk be diversified away by investing in both Apple and MAINZ BIOMED at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apple and MAINZ BIOMED into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apple Inc and MAINZ BIOMED BV, you can compare the effects of market volatilities on Apple and MAINZ BIOMED and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apple with a short position of MAINZ BIOMED. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apple and MAINZ BIOMED.
Diversification Opportunities for Apple and MAINZ BIOMED
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Apple and MAINZ is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Apple Inc and MAINZ BIOMED BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MAINZ BIOMED BV and Apple is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apple Inc are associated (or correlated) with MAINZ BIOMED. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MAINZ BIOMED BV has no effect on the direction of Apple i.e., Apple and MAINZ BIOMED go up and down completely randomly.
Pair Corralation between Apple and MAINZ BIOMED
Assuming the 90 days trading horizon Apple Inc is expected to generate 0.13 times more return on investment than MAINZ BIOMED. However, Apple Inc is 7.97 times less risky than MAINZ BIOMED. It trades about 0.57 of its potential returns per unit of risk. MAINZ BIOMED BV is currently generating about -0.01 per unit of risk. If you would invest 21,355 in Apple Inc on September 15, 2024 and sell it today you would earn a total of 2,260 from holding Apple Inc or generate 10.58% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 95.45% |
Values | Daily Returns |
Apple Inc vs. MAINZ BIOMED BV
Performance |
Timeline |
Apple Inc |
MAINZ BIOMED BV |
Apple and MAINZ BIOMED Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Apple and MAINZ BIOMED
The main advantage of trading using opposite Apple and MAINZ BIOMED positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apple position performs unexpectedly, MAINZ BIOMED can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MAINZ BIOMED will offset losses from the drop in MAINZ BIOMED's long position.The idea behind Apple Inc and MAINZ BIOMED BV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.MAINZ BIOMED vs. Apple Inc | MAINZ BIOMED vs. Apple Inc | MAINZ BIOMED vs. Apple Inc | MAINZ BIOMED vs. Apple Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |